Contraindicated. Coadministration not suggested; potent cytochrome P450 enzyme inducers reduce systemic exposure to roflumilast and will decrease the therapeutic usefulnessWatch Closely (1)phenobarbital will decrease the extent or result of tofacitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Lack of,